January 19, 2021
The Pharma Letter
Kite appoints worldwide head of cell therapy research
Francesco Marincola will join Kite as senior vice president and global head of cell therapy research,... See more »
January 19, 2021
Benzinga
Agenus to Participate in B. Riley Securities' Oncology Investor Conference
LEXINGTON, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ:AGEN), an immuno-oncology com... See more »
January 19, 2021
The Pharma Letter
Kite appoints worldwide head of cell therapy research
Francesco Marincola will join Kite as senior vice president and global head of cell therapy research,... See more »
January 19, 2021
Benzinga
Agenus to Participate in B. Riley Securities' Oncology Investor Conference
LEXINGTON, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ:AGEN), an immuno-oncology com... See more »
Annual Revenue
Employees
CEO
Chris Mirabelli
Leap Therapeutics researches, develops and commercializes monoclonal antibodies that enable immune system to identify and attack cancer cells. Read more
